Atlas Trials

Molecular Characteristics of Brodalumab in Hidradenitis Suppurativa

Clinical trial NCT04979520 · COMPLETED

Trial details

NCT number
NCT04979520
Sponsor
Rockefeller University
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Hidradenitis SuppurativaAcne Inversa
Start date
2021-08-05
Primary completion
2022-07-25
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.